Hormone Signaling and Receptor Pharmacology AOD 9604 is frequently used to investigate selective peptide signaling and receptor pharmacology
Note: 100 units would equate to 2,500mcg & 200 units would equate the total 5,000mcg
FDA Warning Letters and Shortage Resolution The FDA sent 30 warning letters to GLP-1 compounders on February 20, 2026, made public March 3, 2026
After two years of glycemic stability, a slight worsening of metabolic control (HbA1c 7%- 53 mmol/mol) led to an increase of metformin dose (1275 mg/day) and the addition of sitagliptin (50 mg/day)
Despite their efficacy, GLP-1 receptor agonists pose potential challenges and side effects that may impact adoption
While this may initially feel helpful for weight loss, certain individuals struggle to maintain enough calories, fluids, or protein intake throughout the day when hunger levels become too low